Atlas Trials

Rosuvastatin Effect on Telomere-telomerase System in ACS

Clinical trial NCT02299245 · UNKNOWN

Trial details

NCT number
NCT02299245
Sponsor
Xiao-dong Zhuang
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Telomere ShorteningTelomere Length, Mean Leukocyte22q Telomere Deletion Syndrome
Start date
2014-10-01
Primary completion
2016-07-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.